MPWT
NVCR icon

MassMutual Private Wealth & Trust’s NovoCure NVCR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51
Closed -$659 – 2468
2025
Q4 		$659 Sell
51
-94
-65% -$1.21K ﹤0.01% 2210
2025
Q3 		$1.87K Buy
145
+94
+184% +$1.26K ﹤0.01% 2002
2025
Q2 		$908 Sell
51
-33
-39% -$575 ﹤0.01% 2145
2025
Q1 		$1.5K Buy
84
+33
+65% +$749 ﹤0.01% 2011
2024
Q4 		$1.52K Hold
51
– – ﹤0.01% 1911
2024
Q3 		$797 Hold
51
– – ﹤0.01% 1904
2024
Q2 		$874 Buy
51
+30
+143% +$528 ﹤0.01% 1844
2024
Q1 		$328 Buy
+21
New +$309 ﹤0.01% 1925
2023
Q4 		– Sell
-125
Closed -$2.02K – 2044
2023
Q3 		$2.02K Buy
125
+108
+635% +$3.11K ﹤0.01% 1502
2023
Q2 		$706 Buy
17
+2
+13% +$124 ﹤0.01% 1717
2023
Q1 		$902 Sell
15
-4,677
-100% -$374K ﹤0.01% 1593
2022
Q4 		$344K Hold
4,692
– – 0.01% 308
2022
Q3 		$356K Buy
4,692
+4
+0.1% +$312 0.02% 286
2022
Q2 		$326K Buy
4,688
+4,679
+51,989% +$352K 0.01% 300
2022
Q1 		$1K Buy
9
+5
+125% +$368 ﹤0.01% 1374
2021
Q4 		$0 Buy
+4
New +$402 ﹤0.01% 1463

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

MassMutual Private Wealth & Trust's NVCR Position: Q1 2026 in Review

MassMutual Private Wealth & Trust sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 51 shares — an estimated $659 sold.

MassMutual Private Wealth & Trust first reported a position in NVCR in Q4 2021 and held it in 16 quarters. The position peaked at $356K in Q3 2022. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • MassMutual Private Wealth & Trust reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 51 NovoCure shares in Q1 2026, an estimated $659.
  • MassMutual Private Wealth & Trust first reported a position in NovoCure in Q4 2021 and held it in 16 quarters.
  • MassMutual Private Wealth & Trust's NovoCure position peaked at $356K in Q3 2022.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2026, filed 13 Apr 2026.